In the news
Fierce Next Gen: As gene therapies proliferate, pharma and payers look to avoid ‘cost shocks’
June 30, 2022FiercePharma
Related news
In the news
August 3, 2022
Florida Blue Medicare & Prime Therapeutics PBM Pilot Reduced Chronic Opioid Prescriptions By 7%
OPEN MINDS
In the news
July 22, 2022
Prime Therapeutics Reduces Opioid Claims with Targeted Intervention
FormularyWatch